Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Drug hypersensitivity

    Also known as: Drug allergy, Medication hypersensitivity, Allergic drug reaction, Drug-induced hypersensitivity reaction

    Drug hypersensitivity denotes immune-mediated or non-immune adverse reactions to pharmaceutical agents, encompassing clinical presentations from mild exanthema to life-threatening anaphylaxis or delayed systemic syndromes. Clinical management necessitates a precise medication timeline, severity grading, and referral for medical or immunological evaluation; suspected allergens must never be re-introduced under unsupervised conditions. While NSAID pharmacovigilance data highlight reporting signals, they do not establish incidence or comparative safety. Evidence cited herein provides no proof that acupuncture or Chinese herbal formulas effectively treat or prevent drug hypersensitivity. It is critical to recognise that herbal medicines may induce anaphylaxis, and implanted materials, such as acupuncture threads, may precipitate complications. TCM assessment is restricted to optional supportive care following medical stabilisation and must never substitute for allergen avoidance, prescribed pharmacotherapy, specialist investigation, or emergency intervention.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a chronological record of all prescription medications, over-the-counter products, and supplements, documenting initiation dates and the exact timing of any adverse reactions.
    • •Carry an updated allergy record and provide copies to pharmacists, prescribers, and complementary medicine providers, ensuring a clear distinction between suspected and specialist-confirmed hypersensitivities.
    • •Avoid unsupervised re-exposure to suspected allergens and refrain from using substitutes within the same pharmacological class; consult the prescribing clinician for safe alternatives.
    • •Utilise lukewarm water for hygiene, wear non-restrictive clothing, and employ fragrance-free topical products during the period of cutaneous recovery.

    Cautions & Contraindications

    See sources
    • •Do not introduce herbal formulas during an active or unexplained hypersensitivity episode. Herbal constituents and impurities can themselves trigger immediate reactions, including anaphylaxis, and can complicate culprit identification.[]
    • •Avoid thread embedding and animal-derived implanted materials in this adjunctive pathway because foreign-body granulomas and infections have been reported. The case series does not establish a population complication rate.[]
    • •Do not use the NSAID reporting percentages to select a supposedly safe alternative or justify an unsupervised challenge. The study reports pharmacovigilance signals, not individual cross-reactivity or comparative incidence.[]

    When to reassess or seek care again

    See sources

    Medical assessment takes priority for every new suspected reaction. If supportive care is chosen after stabilisation, review within 7–14 days using itch severity on a 0–10 scale, sleep interruption, skin photographs and daily function. Stop adjunctive treatment and arrange immediate medical reassessment for any new or worsening rash or systemic symptoms. Refer back if symptoms persist without improvement at review; seek allergy-specialist assessment where culprit identification or future medicine selection remains uncertain. The supplied correction record [2] contains no usable clinical findings, and none of the supplied abstracts tests adjunctive efficacy.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. International archives of allergy and immunology · 2026
    2. Clinical case reports · 2026
    3. Journal of cosmetic dermatology · 2026
    4. Current opinion in allergy and clinical immunology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.